You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Pierre Fabre Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for PIERRE FABRE, and when can generic versions of PIERRE FABRE drugs launch?

PIERRE FABRE has three approved drugs.

There are two US patents protecting PIERRE FABRE drugs.

There are thirty-nine patent family members on PIERRE FABRE drugs in thirty-one countries.

Summary for Pierre Fabre
International Patents:39
US Patents:2
Tradenames:3
Ingredients:3
NDAs:3
Patent Litigation for Pierre Fabre: See patent lawsuits for Pierre Fabre

Drugs and US Patents for Pierre Fabre

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pierre Fabre NAVELBINE vinorelbine tartrate INJECTABLE;INJECTION 020388-001 Dec 23, 1994 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Pierre Fabre HEMANGEOL propranolol hydrochloride SOLUTION;ORAL 205410-001 Mar 14, 2014 RX Yes Yes 8,338,489 ⤷  Sign Up ⤷  Sign Up
Pierre Fabre HEMANGEOL propranolol hydrochloride SOLUTION;ORAL 205410-001 Mar 14, 2014 RX Yes Yes 8,987,262 ⤷  Sign Up ⤷  Sign Up
Pierre Fabre ETOPOSIDE etoposide INJECTABLE;INJECTION 074813-001 Jul 9, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.